نتائج البحث - "B. De Valk"

1

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

المؤلفون: Andrés Cervantes, H.P. Knol, L. Østergaard, M.L. Lydrup, S.A. Radema, R.F. Schmitz, P. Nieboer, J. Hol, I. Edhemovic, K.C.M.J. Peeters, A. Johnsson, F.J.F. Jeurissen, Pieter J. Tanis, A.C.M. van de Luijtgaarden, P. Quarles an Ufford, H. Kim, Hein Putter, W.A. Bleeker, Tone Fokstuen, M E van Leerdam, K. Kovacs, A. Pronk, E.D. Kerver, L.G.H. Dewit, E. Garcia Granero, P.A. Nijenhuis, T. Fokstuen, S. Ottosson, P. Flygare, M.J. Safont, Iris D. Nagtegaal, F. Svendsen Jensen, C. Bratthäll, H.M. Ceha, L. Malmberg, P. Hede, W.M. van der Deure, G. Carlsson, J. Haux, Derk Jan A. de Groot, Esmée A Dijkstra, Renu R. Bahadoer, G.A.P. Nieuwenhuijzen, B. de Valk, B. Lindh, D. Hess, G.L. Beets, J.C. Bernal, A.M.E. Bruynzeel, R.M.P.H. Crolla, C. Kersten, P. Pfeiffer, S. Biondo, M.L. Silviera, Jannet C. Beukema, W.H. Schreurs, O. Hallböök, B.L. Lödén, A. Espí Macías, V. Velenik, L. Österlund, A. Slot, Geke A. P. Hospers, H. de Wilt, A.W.K.S. Marinelli, O. Lundberg, C. Radu, J. die Trill, I. Verbiené, P. Matthiessen, Mathijs P. Hendriks, J.H.M. Bekker, M. Walldén, V. Pachón, H.W. Kapiteijn, J.M. Immink, A. Piwowar, R. Salazar, L. Påhlman, P. Braam, K.E.J. Jensen, S. Festen, O. Mjåland, Elma Meershoek-Klein Kranenbarg, Jaume Capdevila, U. Palenius, K. Villmann, J.J. van der Vliet, Albert J. ten Tije, A. Berglund, Corrie A.M. Marijnen, G. Dafnis, J. Assarsson, J. Capdevila, J.W.T. Dekker, M. Grønlie Guren, G.J. Veldhuis, Q.A.J. Eijsbouts, G.J. Creemers, J.B. Tuynman, C.J.A. Punt, P.H.J.M. Veldman, J. Aparicio, Klaas Havenga, E.D. Geijsen, W.H. Steup, T. Rozema, K. Smedh, Lennart Blomqvist, J. de Boer, Cornelis J.H. van de Velde, S. Jangmalm, J.W.P. Vanstiphout, T.C. Stam, A.C.M. van den Bergh, Annet G H Roodvoets, Janet R. Vos, E.J.M. Siemerink, R.J.I. Bosker, Bengt Glimelius, A. Cervantes, E. Espin, Per Nilsson, A.J. Ten Tije, Ibrahim Edhemovic, Boudewijn van Etten, M. Tascilar, A.N. Nesbakken, G.A. Patijn, O. Reerink, Regina G. H. Beets-Tan, S. Skullman, H. Hörberg, P. Parinkh, G. Svaninger, M.B. Polée, D. Ten Bokkel Huinink, C. Hoff, A.F.T. Olieman, H. van den Berg, F.P. Peters, Torbjörn Holm, J.M. van Rooijen, M.P. Hendriks, J. Benedik, J.H. Svensson, A.L.T. Imholz

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Surgery, CCA - Cancer Treatment and quality of life, Amsterdam Gastroenterology Endocrinology Metabolism, Radiation Oncology, Internal medicine, VU University medical center, Ophthalmology, Amsterdam Neuroscience - Systems & Network Neuroscience, Oncology, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Radiotherapy, Paediatric Oncology

المصدر: Lancet Oncology, 22, 29-42
Lancet Oncology, 22(1), 29-42. ELSEVIER SCIENCE INC
the RAPIDO collaborative investigators 2021, ' Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial ', The Lancet Oncology, vol. 22, no. 1, pp. 29-42 . https://doi.org/10.1016/S1470-2045Test(20)30555-6
The Lancet Oncology, 22(1), 29-42. ELSEVIER SCIENCE INC
The Lancet. Oncology
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Lancet Oncology, 22, 1, pp. 29-42
The Lancet Oncology, 22(1), 29-42. ELSEVIER
The Lancet Oncology, 22(1), 29-42. Lancet Publishing Group
lancet oncology, 22(1), 29-42. Lancet Publishing Group

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Population, law.invention, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], 03 medical and health sciences, Folinic acid, All institutes and research themes of the Radboud University Medical Center, 0302 clinical medicine, Randomized controlled trial, law, Tumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14], medicine, Clinical endpoint, education, education.field_of_study, Performance status, business.industry, Total mesorectal excision, Oxaliplatin, Surgery, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, business, Chemoradiotherapy, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81d055e24de581f7d953a2dafec480d7Test
https://doi.org/10.1016/s1470-2045Test(20)30555-6

2

LBA21 FOLFOX/FOLFIRI plus either bevacizumab or panitumumab in patients with initially unresectable colorectal liver metastases (CRLM) and left-sided and RAS/BRAFV600E wild-type tumour: Phase III CAIRO5 study of the Dutch Colorectal Cancer Group

المصدر: Annals of Oncology. 33:S1389

مصطلحات موضوعية: Oncology, Hematology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::2184fb810269dba46507e0a7a9801214Test
https://doi.org/10.1016/j.annonc.2022.08.017Test

3

Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study

المؤلفون: A.A. van de Loosdrecht, F. de Boer, Saskia K. Klein, J. Pruijt, B. de Valk, Edo Vellenga, B.P. van Rees, W.J.F.M. van der Velden, Leo F. Verdonck, Gerwin Huls, Marjan Cruijsen, Nicole M. A. Blijlevens, E. van der Spek, Mels Hoogendoorn, Y. Tromp, A.F.J. de Haan

المساهمون: Stem Cell Aging Leukemia and Lymphoma (SALL), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Hematology, CCA - Cancer Treatment and quality of life

المصدر: Leukemia & Lymphoma, 61(11), 2752-2755. TAYLOR & FRANCIS LTD
Leukemia & Lymphoma, 61, 2752-2755
Leukemia & Lymphoma, 61, 11, pp. 2752-2755
Leukemia and Lymphoma, 61(11), 2752-2755. Informa Healthcare
Cruijsen, M, van der Velden, W J F M, de Haan, A F J, Klein, S K, Hoogendoorn, M, Tromp, Y, de Valk, B, van Rees, B, de Boer, F, van der Spek, E, Pruijt, J, Verdonck, L F, Vellenga, E, Blijlevens, N, van de Loosdrecht, A A & Huls, G 2020, ' Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands : the OCEAN study ', Leukemia and Lymphoma, vol. 61, no. 11, pp. 2752-2755 . https://doi.org/10.1080/10428194.2020.1775217Test

مصطلحات موضوعية: Antimetabolites, Antineoplastic, Cancer Research, medicine.medical_specialty, Azacitidine, MEDLINE, 03 medical and health sciences, 0302 clinical medicine, Clinical decision making, hemic and lymphatic diseases, medicine, MDS, Humans, Intensive care medicine, Netherlands, RISK MYELODYSPLASTIC SYNDROMES, business.industry, Other Research Radboud Institute for Health Sciences [Radboudumc 0], Cancer, Hematology, medicine.disease, CANCER, Clinical Practice, Treatment Outcome, Oncology, Myelodysplastic Syndromes, 030220 oncology & carcinogenesis, Inflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5], business, 030215 immunology, medicine.drug, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38f2ea5a8664a1f0d9ef5596b2925927Test
https://research.rug.nl/en/publications/6f589496-7d1d-40a0-a479-356e1e47405cTest

4

Ribociclib (RIB) + letrozole (LET) in patients (pts) with visceral metastases (VM) or bone-only metastases (BOM) in hormone receptor-positive (HR+), human epidermal growth factor receptor-2–negative (HER2–) advanced breast cancer (ABC): Subgroup analysis from the CompLEEment-1 trial

المؤلفون: Alistair Ring, Andrea Gombos, Thomas Bachelot, Katie Zhou, Piero Marchetti, B. De Valk, L. Menon-Singh, M. Campone, Constanta Timcheva, M. De Laurentiis, J. Wu, William Jacot, Patrick Neven

المصدر: Annals of Oncology. 30:v117-v118

مصطلحات موضوعية: education.field_of_study, medicine.medical_specialty, Time to progression, business.industry, Advanced breast, Population, Endocrine therapy, Ribociclib, Hematology, Tumor response, Oncology, Family medicine, Medicine, In patient, education, business, Human Epidermal Growth Factor Receptor 2

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::930e50260012d93fe19a8b741947a43aTest
https://doi.org/10.1093/annonc/mdz242.027Test

5

Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

المؤلفون: Ignace Vergote, Corneel Coens, Matthew Nankivell, Gunnar B Kristensen, Mahesh K B Parmar, Tom Ehlen, Gordon C Jayson, Nick Johnson, Ann Marie Swart, René Verheijen, W Glenn McCluggage, Tim Perren, Pierluigi Benedetti Panici, Gemma Kenter, Antonio Casado, Cesar Mendiola, Gavin Stuart, Nick S Reed, Sean Kehoe, Claes Tropé G., Stephen Dobbs, Sharadah Essapen, P. Hoskins, John Green, E. Gilby, M. Van Baal, Jeremy Twigg, Maria E.L. Van Der Burg, Keith Godfrey, Angel J. Lacave, R. Angioli, Rahul Nath, Kirk Chin, Charles Redman, R. Lotocki, Adeola Olaitan, B. Mosgaard, G. Rustin, Thomas Ind, Mojca Persic, Martin Hogg, J. Van Der Velden, J. Ledermann, Peter Sykes Peter Sykes, Krishnawam Madhavan, P. Kannisto, Vicky Hird, A. Evans, R. Sandvei R., P. Gauthier, D.J. Cruickshank, P.B. Ottevanger, Sheila Pearson, Henry Kitchener, Marcia Hall, P. Bessette, S. Pecorelli, E. Gerdin, Tito Lopes, Andrew Fish, Clare Barlow., K. Van Eygen, A. Floquet, B. Tholander, N. Gul, Robert Gornall, David Luesley, Philip Kirwan, Paul Symonds, Richard Henry, David Poole, Ian McNeish, Mark Hocking, Al Sammaraie, P. Speiser, E. Leblanc, J.A. Green, C.F. De Oliveira, R. Grimshaw, P. Zola, David Parkin, Martin Lamb, Anne Hong, Alan Gillespie, Abdel Hamid, Ahmed Ahmed, M. Plante, B. De Valk, A. Nordin, Andrew Clamp, David Perez, Graham Dark Graham Dark, Michelle Ferguson, Carol MacGregor, Geraldine Skailes, Rachel Jones, G. Cawdell, Simon Leeson, L. Elit, C. Dittrich, W. Gotlieb, John Cullimore, Barbara Crosse, Paul Ridley, Anthony Head, Joaquin Nieto, Saif Awwad, Dirk Brinkmann, Damian Eustace, Andrew Hindley, D. Katsaros, C. Popadiuk, Tome Kristeller, C. Redman, S. Chan, C. Marth, Dennis Yiannakis, Kate Lankaster, Gareth Beynon, Anwar Suhail, Fernando Indrajit, Mary Quigley, Olu Adeyemi, Fiona Lofts, Orla McNally, Amanda Tristam, Martin Lee, R. Counsell, N. Gleeson, A. Papadopoulos, T. Maggino, A. Honkoop, P. Ghatage, J.B. Vermorken, J. De Greve, K. Boman, E Petru, F. Amant

المساهمون: VU University medical center, CCA - Cancer Treatment and quality of life, Amsterdam Reproduction & Development (AR&D), Obstetrics and gynaecology, Obstetrics and Gynaecology, CCA -Cancer Center Amsterdam, Physiology, ACS - Heart failure & arrhythmias

المصدر: Lancet Oncology, 19, 12, pp. 1680-1687
Obstetrical and Gynecological Survey, 74(3), 156-158. Lippincott Williams and Wilkins
MRC CHORUS study investigators 2018, ' Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials ', The Lancet Oncology, vol. 19, no. 12, pp. 1680-1687 . https://doi.org/10.1016/S1470-2045Test(18)30566-7
Vergote, I, Coens, C, Nankivell, M, Kristensen, G B, Parmar, M K B, Ehlen, T, Jayson, G C, Johnson, N, Swart, A M, Verheijen, R, McCluggage, W G, Perren, T, Panici, P B, Kenter, G, Casado, A, Mendiola, C, Stuart, G, Reed, N S & Kehoe, S 2019, ' Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: Pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials ', Obstetrical and Gynecological Survey, vol. 74, no. 3, pp. 156-158 . https://doi.org/10.1097/01.ogx.0000554460.78765.59Test
Jayson, G 2018, ' Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials. ', Lancet Oncology, vol. 19, no. 12, pp. 1680-1687 . https://doi.org/10.1016/S1470-2045Test(18)30566-7
Lancet Oncology, 19, 1680-1687
The Lancet Oncology, 19(12), 1680-1687. Lancet Publishing Group

مصطلحات موضوعية: 0301 basic medicine, Oncology, Tubo-ovarian, Time Factors, FIGO Stage IIIA, medicine.medical_treatment, 0302 clinical medicine, Gynecologic Surgical Procedures, Risk Factors, Multicenter Studies as Topic, Stage (cooking), Peritoneal Neoplasms, Randomized Controlled Trials as Topic, Ovarian Neoplasms, Manchester Cancer Research Centre, Hazard ratio, Obstetrics and Gynecology, General Medicine, Cytoreduction Surgical Procedures, Middle Aged, Debulking, Neoadjuvant Therapy, Progression-Free Survival, Tumor Burden, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], EORTC, Pooled analysis, 030220 oncology & carcinogenesis, Female, medicine.medical_specialty, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, Internal medicine, Carcinoma, medicine, Fallopian Tube Neoplasms, Humans, Stage IIIC, 1112 Oncology and Carcinogenesis, Oncology & Carcinogenesis, Aged, Neoplasm Staging, Chemotherapy, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, Cancer, Patient data, medicine.disease, Surgery, 030104 developmental biology, Ovarian cancer, business, MRC CHORUS study investigators

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f32bf7e089ed9921db1ad91c3ad4e088Test
https://hdl.handle.net/2066/200265Test

6

Cardiac safety, efficacy, and correlation of serial serum HER2-extracellular domain shed antigen measurement with the outcome of the combined trastuzumab plus CMF in women with HER2-positive metastatic breast cancer : results from the EORTC 10995 phase II study

المؤلفون: Laura Biganzoli, M. Welnicka-Jaskiewicz, Sandrine Marreaud, John M. S. Bartlett, Konstantinos Tryfonidis, Jan B. Vermorken, B. De Valk, Hussein M. Khaled, David Cameron, Jan Bogaerts, K Aalders

المساهمون: EORTC-Breast Canc Grp

المصدر: Breast cancer research and treatment
Tryfonidis, K, Marreaud, S, Khaled, H, De Valk, B, Vermorken, J, Welnicka-jaskiewicz, M, Aalders, K, Bartlett, J M S, Biganzoli, L, Bogaerts, J & Cameron, D 2017, ' Cardiac safety, efficacy, and correlation of serial serum HER2-extracellular domain shed antigen measurement with the outcome of the combined trastuzumab plus CMF in women with HER2-positive metastatic breast cancer: results from the EORTC 10995 phase II study ', Breast cancer research and treatment . https://doi.org/10.1007/s10549-017-4203-yTest

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, Anthracycline, Receptor, ErbB-2, medicine.medical_treatment, Phases of clinical research, Breast Neoplasms, Antibodies, Monoclonal, Humanized, Asymptomatic, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Trastuzumab, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Anthracyclines, 030212 general & internal medicine, Neoplasm Metastasis, skin and connective tissue diseases, Cyclophosphamide, Chemotherapy, Cardiotoxicity, business.industry, Heart, medicine.disease, Metastatic breast cancer, Methotrexate, 030220 oncology & carcinogenesis, Female, Fluorouracil, Human medicine, medicine.symptom, business, medicine.drug